These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9088596)

  • 1. The interaction of terbinafine and cyclosporine A in renal transplant patients.
    Lo AC; Lui SL; Lo WK; Chan DT; Cheng IK
    Br J Clin Pharmacol; 1997 Mar; 43(3):340-1. PubMed ID: 9088596
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of the efficacy and tolerability of oral terbinafine in the treatment of onychomycosis in renal transplant patients.
    Lee KH; Kim YS; Kim MS; Chung HS; Park K
    Transplant Proc; 1996 Jun; 28(3):1488-9. PubMed ID: 8658754
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of oral terbinafine treatment on cyclosporin pharmacokinetics in organ transplant recipients with dermatophyte nail infection.
    Jensen P; Lehne G; Fauchald P; Simonsen S
    Acta Derm Venereol; 1996 Jul; 76(4):280-1. PubMed ID: 8869684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine for onychomycosis.
    Med Lett Drugs Ther; 1996 Aug; 38(981):72-4. PubMed ID: 8699988
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections.
    Cribier BJ; Bakshi R
    Br J Dermatol; 2004 Mar; 150(3):414-20. PubMed ID: 15030322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of proximal white subungual onychomycosis with oral terbinafine therapy.
    Aman S; Nadeem M; Haroon TS
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):728-9. PubMed ID: 18983803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating onychomycosis.
    Rodgers P; Bassler M
    Am Fam Physician; 2001 Feb; 63(4):663-72, 677-8. PubMed ID: 11237081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
    Warrick D; Church L
    J Fam Pract; 1999 Jul; 48(7):492-3. PubMed ID: 10428238
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT; Voytovich RM; Jan SA
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of onychomycoses with terbinafine (Lamisil)].
    Baudraz F; Rakosi T
    Rev Med Suisse Romande; 1998 Nov; 118(11):975-9. PubMed ID: 9865129
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of onychomycosis in children.
    Gupta AK; De Rosso JQ
    Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined surgical and systemic treatment of onychomycosis.
    Dominguez-Cherit J; Teixeira F; Arenas R
    Br J Dermatol; 1999 Apr; 140(4):778-80. PubMed ID: 10233357
    [No Abstract]   [Full Text] [Related]  

  • 20. Onychomycosis and diabetes.
    Cathcart S; Cantrell W; Elewski Be
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1119-22. PubMed ID: 19309423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.